Physeter catodon (sperm whale): 102983230
Help
Entry
102983230 CDS
T06011
Gene name
PLCG2
Definition
(RefSeq) 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2
KO
K05859
phosphatidylinositol phospholipase C, gamma-2 [EC:
3.1.4.11
]
Organism
pcad
Physeter catodon (sperm whale)
Pathway
pcad00562
Inositol phosphate metabolism
pcad01100
Metabolic pathways
pcad01521
EGFR tyrosine kinase inhibitor resistance
pcad04012
ErbB signaling pathway
pcad04014
Ras signaling pathway
pcad04020
Calcium signaling pathway
pcad04062
Chemokine signaling pathway
pcad04064
NF-kappa B signaling pathway
pcad04066
HIF-1 signaling pathway
pcad04070
Phosphatidylinositol signaling system
pcad04072
Phospholipase D signaling pathway
pcad04360
Axon guidance
pcad04370
VEGF signaling pathway
pcad04380
Osteoclast differentiation
pcad04611
Platelet activation
pcad04613
Neutrophil extracellular trap formation
pcad04625
C-type lectin receptor signaling pathway
pcad04650
Natural killer cell mediated cytotoxicity
pcad04662
B cell receptor signaling pathway
pcad04664
Fc epsilon RI signaling pathway
pcad04666
Fc gamma R-mediated phagocytosis
pcad04670
Leukocyte transendothelial migration
pcad04722
Neurotrophin signaling pathway
pcad04750
Inflammatory mediator regulation of TRP channels
pcad04919
Thyroid hormone signaling pathway
pcad04933
AGE-RAGE signaling pathway in diabetic complications
pcad04935
Growth hormone synthesis, secretion and action
pcad05167
Kaposi sarcoma-associated herpesvirus infection
pcad05169
Epstein-Barr virus infection
pcad05170
Human immunodeficiency virus 1 infection
pcad05171
Coronavirus disease - COVID-19
pcad05200
Pathways in cancer
pcad05205
Proteoglycans in cancer
pcad05206
MicroRNAs in cancer
pcad05214
Glioma
pcad05223
Non-small cell lung cancer
pcad05225
Hepatocellular carcinoma
Module
pcad_M00130
Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4
Brite
KEGG Orthology (KO) [BR:
pcad00001
]
09100 Metabolism
09101 Carbohydrate metabolism
00562 Inositol phosphate metabolism
102983230 (PLCG2)
09130 Environmental Information Processing
09132 Signal transduction
04012 ErbB signaling pathway
102983230 (PLCG2)
04014 Ras signaling pathway
102983230 (PLCG2)
04370 VEGF signaling pathway
102983230 (PLCG2)
04064 NF-kappa B signaling pathway
102983230 (PLCG2)
04066 HIF-1 signaling pathway
102983230 (PLCG2)
04020 Calcium signaling pathway
102983230 (PLCG2)
04070 Phosphatidylinositol signaling system
102983230 (PLCG2)
04072 Phospholipase D signaling pathway
102983230 (PLCG2)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
102983230 (PLCG2)
04613 Neutrophil extracellular trap formation
102983230 (PLCG2)
04625 C-type lectin receptor signaling pathway
102983230 (PLCG2)
04650 Natural killer cell mediated cytotoxicity
102983230 (PLCG2)
04662 B cell receptor signaling pathway
102983230 (PLCG2)
04664 Fc epsilon RI signaling pathway
102983230 (PLCG2)
04666 Fc gamma R-mediated phagocytosis
102983230 (PLCG2)
04670 Leukocyte transendothelial migration
102983230 (PLCG2)
04062 Chemokine signaling pathway
102983230 (PLCG2)
09152 Endocrine system
04935 Growth hormone synthesis, secretion and action
102983230 (PLCG2)
04919 Thyroid hormone signaling pathway
102983230 (PLCG2)
09156 Nervous system
04722 Neurotrophin signaling pathway
102983230 (PLCG2)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
102983230 (PLCG2)
09158 Development and regeneration
04360 Axon guidance
102983230 (PLCG2)
04380 Osteoclast differentiation
102983230 (PLCG2)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
102983230 (PLCG2)
05206 MicroRNAs in cancer
102983230 (PLCG2)
05205 Proteoglycans in cancer
102983230 (PLCG2)
09162 Cancer: specific types
05225 Hepatocellular carcinoma
102983230 (PLCG2)
05214 Glioma
102983230 (PLCG2)
05223 Non-small cell lung cancer
102983230 (PLCG2)
09167 Endocrine and metabolic disease
04933 AGE-RAGE signaling pathway in diabetic complications
102983230 (PLCG2)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
102983230 (PLCG2)
05171 Coronavirus disease - COVID-19
102983230 (PLCG2)
05167 Kaposi sarcoma-associated herpesvirus infection
102983230 (PLCG2)
05169 Epstein-Barr virus infection
102983230 (PLCG2)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
102983230 (PLCG2)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:
pcad04131
]
102983230 (PLCG2)
Enzymes [BR:
pcad01000
]
3. Hydrolases
3.1 Acting on ester bonds
3.1.4 Phosphoric-diester hydrolases
3.1.4.11 phosphoinositide phospholipase C
102983230 (PLCG2)
Membrane trafficking [BR:
pcad04131
]
Exocytosis
Calcium ion-dependent exocytosis
Phospholipases
102983230 (PLCG2)
Endocytosis
Macropinocytosis
Phospholipase C
102983230 (PLCG2)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
PI-PLC-X
SH2
PI-PLC-Y
C2
SH3_1
SH3_9
PH
SH3_2
PH_12
PH_14
EF-hand_like
Motif
Other DBs
NCBI-GeneID:
102983230
NCBI-ProteinID:
XP_023980747
UniProt:
A0A2Y9STJ9
LinkDB
All DBs
Position
17
AA seq
1265 aa
AA seq
DB search
MSTAVNVDALPEYEKSQIKRALELGTVMTVFSFRKSTPERRTVQVIMETQQVAWSKTADK
IEGFLDIMEIKEIRPGKNSKDFERAKAVRQKEECCFTILYGTQFVLSTLSLAADSKEDAT
KWLSGLKILHQEVMSASTPTIIESWLRKQIYSVDQTRRNSISLRELKTILPLVNFKVSSA
KFLKDKFVEIGAHKDELSFEQFHLFYKKLMFEQQKLILDEFKKDSSVFILGNTDRPDASA
VHLHDFQRFLSHEQQELWAQDLNKVRERMTKFIDDTMRETAEPFLFVDEFLTYLFSRENS
IWDEKYDVVDVQEMNNPLSHYWISSSHNTYLTGDQLRSESSPEAYIRCLRMGCRCIELDC
WDGPDGKPIIYHGWTRTTKIKFDDVVQAIKDHAFVTSSFPVILSIEEHCCVEQQRHMARV
FREVFGDLLLTKPTEASADQLPSPSQLREKIIIKHKKLGPRGDVDVNMEDKKDEHKQQGE
LYMWDSIDQKWTRHYCAIADAKLSFSDDIEQTVEGEQPPDIAPTELHFGEKWFHKKVEKR
TSAEKLLQEYCAETGGKDGTFLVRESETYPNDYTLSFWRSGRVQHCRIRSTVEGGTLKYY
LTDNLMFTSIYALIQHYSETHLRCAEFELRLTDPVPNPSPHKSKPWYYDGLSRGEAEDML
MRVPRDGAFLIRKREGTDSYAITFRARGKVKHCRINRDGRHFVLGTSAYFESLVELVSYY
EKHALYRKMRLRYPVTPELLERYNMERDINSLYDVSRMYVDPSEINPSMPQRTVKALYDY
KAKQSDELSFCRGALIHNVSKEPGGWWKGDYGTRIQQYFPSNYVEDISTADGEELEKQII
EDNPLGSLCRGILDLNTYNVVKAPQGKNQKPFVFILEPKKQGDPPVEFATDKVEELFEWF
QSIREITWKIDTKENNMKYWEKNQSIAIELSDLVVYCKPTSKTKDNLENPDFREIRSFVE
TKADSVVRQKPNDLLKYNQKGLTRVYPKGQRVDSSNYDPFRLWLCGSQMVALNFQTPDKY
LQMNHALFSLNGRTGYVLQPESMRAEKYDPMPPEAQRKILMTLTVKVLGARHLPKPGRSI
ACPFVEVEICGAEYDNNKFKTTVVNDNGLSPVWAPTQEKVTFEIYDPNLAFLRFVVYEED
MFSDPNFLAHATFPIKGIKSGFRSVPLKNGYSEDLELASLLVFCEMRPVLESEEELYSSC
RQLRRRQEELNNQLFLYDTHQNLRNANRDALVREFNVNENQLQLYQEKCNRRLREKRVSN
SKFYS
NT seq
3798 nt
NT seq
+upstream
nt +downstream
nt
atgagcaccgcggtcaatgttgacgcccttccggagtacgagaagagtcagatcaagagg
gccctggagctgggcacggtgatgacagtgttcagcttccgcaagtccaccccggagcgg
aggaccgtccaggtgatcatggagacccagcaggtggcctggagcaagacggccgataag
atcgagggcttcctggatatcatggaaataaaggaaatccgcccagggaagaactccaag
gattttgagcgtgcgaaagcagtccgccagaaggaagagtgctgcttcaccatcttgtac
ggcacccagttcgtcctcagcacgctcagcttagcagccgactctaaagaagatgcaact
aagtggctctctggcttgaagatcttacaccaggaagtgatgagcgcatccacccccacc
atcattgagagttggttgagaaagcagatttattctgtggatcaaaccagaagaaacagc
atcagcctccgagagttgaagaccatcttgcccctggtcaacttcaaagtgagcagcgcc
aagttcctcaaagataagttcgtggaaataggcgcacacaaagatgaactcagctttgaa
cagttccatctcttctataaaaaacttatgtttgaacagcaaaaattgattcttgacgaa
ttcaaaaaggattcctccgtgttcatcttgggcaacaccgaccggccggatgcctccgct
gttcacctgcacgacttccagaggtttctctcacatgaacagcaggagctttgggctcag
gatctgaacaaagtccgtgagcggatgacaaagttcattgatgacaccatgcgagaaact
gccgagcccttcctgtttgtggatgagttcctcacgtacctgttttcccgggagaacagc
atttgggacgagaagtatgacgtggtggatgtgcaggaaatgaacaaccccttgtcgcat
tactggatctcctcatcacataacacgtacctcacgggtgaccagcttcggagcgagtcg
tccccggaggcctatatccgctgtctgcggatgggctgccgctgcattgagctggactgc
tgggacgggcccgacgggaagcccatcatctaccacggctggacgcggaccaccaagatc
aagtttgatgacgtcgtgcaggccatcaaagaccatgcctttgtcacctcgagcttcccc
gtgatcctgtccatcgaggagcactgctgcgtggagcagcagcgccacatggcccgggtg
ttcagggaggtgttcggcgacctgctgctgaccaagcccacggaggccagtgccgaccag
ctgccgtcgcccagccagctgcgggagaagatcatcatcaagcataagaagctgggcccc
cgaggcgacgtggatgtcaacatggaggacaagaaagatgaacacaagcagcagggtgaa
ctgtacatgtgggattccatcgaccagaaatggactcggcactactgtgccattgctgat
gccaagctgtccttcagcgatgacattgaacagactgtggaaggtgaacagcccccggat
atagcccccacggagctgcattttggggagaagtggttccacaagaaggtggagaagagg
acaagtgccgagaagctgctgcaggaatactgcgccgagacggggggcaaggatgggacc
ttcttggtgcgggagagcgagacctaccccaatgactacaccctgtccttctggcggtcg
ggccgcgtccagcactgccggatccgctccaccgtggagggcgggaccctgaagtattac
ctgactgacaacctcatgtttaccagcatctacgccctcatccagcactacagcgagacg
cacctgcgctgtgccgagttcgagctccggctcaccgacccagttcccaaccccagcccg
cacaagtcgaagccgtggtactacgatgggctgagccgtggagaagcggaggacatgctg
atgagggttccccgggatggcgccttcctgatccggaagcgggaaggtaccgactcctac
gccatcaccttcagggccaggggcaaggtgaagcactgtcgcatcaaccgggacggccgg
cacttcgtgctgggcacctccgcctacttcgagagcctcgtggagctggtcagctactac
gagaagcacgcactctaccggaagatgagactgcgctaccccgtgacccccgagctcctg
gagcggtacaacatggaaagagatataaactccctctatgacgtcagcaggatgtatgtg
gatcccagtgaaatcaatccttccatgcctcagagaaccgtgaaagctctgtatgactac
aaagccaagcaaagcgatgagctgagcttctgccgtggtgccctcatccacaacgtctcc
aaggagcctgggggctggtggaaaggagactacggaaccagaatccagcagtacttcccg
tccaattacgttgaagacatttcaacagctgatggagaggagctggaaaagcagattatt
gaagacaatcccttagggtctctttgcagaggaatactggatctcaacacctataatgtt
gtaaaagccccacaggggaagaaccagaaacctttcgtctttatcttggagcccaagaag
cagggtgaccctccggtggagtttgccacagacaaggtggaggagctgttcgagtggttc
cagagcatccgggagatcacctggaagatcgacaccaaggagaacaacatgaagtactgg
gagaagaaccagtccatcgccatcgagctctcggacctggtcgtctactgcaaaccgacc
agcaagaccaaggacaacctagaaaaccccgacttccgagaaatccgctccttcgtggag
acaaaggctgacagcgtcgtcagacagaaacccaacgatctcttgaaatacaatcaaaag
ggcctgacccgcgtttaccccaagggacagcgggtggactcctccaactacgaccccttc
cgcctctggctgtgtggctcccagatggtggcactcaatttccagactccagataagtac
ctgcagatgaatcacgccctgttttccctcaacgggcggactggctacgtcctgcagccc
gagagcatgagggcggagaagtacgaccccatgccgcccgaggcgcagaggaagatcctg
atgactctgacggtcaaggttctgggggctcgtcatctccccaaacctggacgaagtatc
gcatgtccctttgtggaggtggaaatatgcggagccgaatatgacaacaacaagttcaaa
acaacagttgtgaatgacaacggcctaagccctgtttgggctccgacacaggagaaggtg
acgtttgaaatttatgacccaaacctcgcgtttctgcgctttgtggtttacgaggaagat
atgttcagcgatcccaactttctcgcgcatgccactttccccattaaaggaatcaagtca
ggatttagatctgttcctctgaagaacggctacagtgaagacctggagctggcttccctc
ctggttttctgtgagatgcggccagtcctggagagcgaagaggagctttactcctcctgc
cgccagctgcggaggcggcaagaagagctgaacaaccagctctttctgtacgacacacac
cagaacctgcgcaacgccaaccgggacgccctggtcagagagttcaacgtcaacgagaac
cagctgcagctgtaccaggagaagtgcaaccgcaggttaagagagaagagagtcagcaac
agcaagttttactcatag
Physeter catodon (sperm whale): 102992700
Help
Entry
102992700 CDS
T06011
Gene name
PLCG1
Definition
(RefSeq) 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1
KO
K01116
phosphatidylinositol phospholipase C, gamma-1 [EC:
3.1.4.11
]
Organism
pcad
Physeter catodon (sperm whale)
Pathway
pcad00562
Inositol phosphate metabolism
pcad01100
Metabolic pathways
pcad01521
EGFR tyrosine kinase inhibitor resistance
pcad04012
ErbB signaling pathway
pcad04014
Ras signaling pathway
pcad04015
Rap1 signaling pathway
pcad04020
Calcium signaling pathway
pcad04062
Chemokine signaling pathway
pcad04064
NF-kappa B signaling pathway
pcad04066
HIF-1 signaling pathway
pcad04070
Phosphatidylinositol signaling system
pcad04072
Phospholipase D signaling pathway
pcad04360
Axon guidance
pcad04370
VEGF signaling pathway
pcad04613
Neutrophil extracellular trap formation
pcad04650
Natural killer cell mediated cytotoxicity
pcad04658
Th1 and Th2 cell differentiation
pcad04659
Th17 cell differentiation
pcad04660
T cell receptor signaling pathway
pcad04664
Fc epsilon RI signaling pathway
pcad04666
Fc gamma R-mediated phagocytosis
pcad04670
Leukocyte transendothelial migration
pcad04722
Neurotrophin signaling pathway
pcad04750
Inflammatory mediator regulation of TRP channels
pcad04919
Thyroid hormone signaling pathway
pcad04933
AGE-RAGE signaling pathway in diabetic complications
pcad04935
Growth hormone synthesis, secretion and action
pcad05012
Parkinson disease
pcad05022
Pathways of neurodegeneration - multiple diseases
pcad05135
Yersinia infection
pcad05167
Kaposi sarcoma-associated herpesvirus infection
pcad05170
Human immunodeficiency virus 1 infection
pcad05171
Coronavirus disease - COVID-19
pcad05200
Pathways in cancer
pcad05205
Proteoglycans in cancer
pcad05206
MicroRNAs in cancer
pcad05214
Glioma
pcad05223
Non-small cell lung cancer
pcad05225
Hepatocellular carcinoma
pcad05231
Choline metabolism in cancer
pcad05235
PD-L1 expression and PD-1 checkpoint pathway in cancer
Module
pcad_M00130
Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4
Brite
KEGG Orthology (KO) [BR:
pcad00001
]
09100 Metabolism
09101 Carbohydrate metabolism
00562 Inositol phosphate metabolism
102992700 (PLCG1)
09130 Environmental Information Processing
09132 Signal transduction
04012 ErbB signaling pathway
102992700 (PLCG1)
04014 Ras signaling pathway
102992700 (PLCG1)
04015 Rap1 signaling pathway
102992700 (PLCG1)
04370 VEGF signaling pathway
102992700 (PLCG1)
04064 NF-kappa B signaling pathway
102992700 (PLCG1)
04066 HIF-1 signaling pathway
102992700 (PLCG1)
04020 Calcium signaling pathway
102992700 (PLCG1)
04070 Phosphatidylinositol signaling system
102992700 (PLCG1)
04072 Phospholipase D signaling pathway
102992700 (PLCG1)
09150 Organismal Systems
09151 Immune system
04613 Neutrophil extracellular trap formation
102992700 (PLCG1)
04650 Natural killer cell mediated cytotoxicity
102992700 (PLCG1)
04660 T cell receptor signaling pathway
102992700 (PLCG1)
04658 Th1 and Th2 cell differentiation
102992700 (PLCG1)
04659 Th17 cell differentiation
102992700 (PLCG1)
04664 Fc epsilon RI signaling pathway
102992700 (PLCG1)
04666 Fc gamma R-mediated phagocytosis
102992700 (PLCG1)
04670 Leukocyte transendothelial migration
102992700 (PLCG1)
04062 Chemokine signaling pathway
102992700 (PLCG1)
09152 Endocrine system
04935 Growth hormone synthesis, secretion and action
102992700 (PLCG1)
04919 Thyroid hormone signaling pathway
102992700 (PLCG1)
09156 Nervous system
04722 Neurotrophin signaling pathway
102992700 (PLCG1)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
102992700 (PLCG1)
09158 Development and regeneration
04360 Axon guidance
102992700 (PLCG1)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
102992700 (PLCG1)
05206 MicroRNAs in cancer
102992700 (PLCG1)
05205 Proteoglycans in cancer
102992700 (PLCG1)
05231 Choline metabolism in cancer
102992700 (PLCG1)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
102992700 (PLCG1)
09162 Cancer: specific types
05225 Hepatocellular carcinoma
102992700 (PLCG1)
05214 Glioma
102992700 (PLCG1)
05223 Non-small cell lung cancer
102992700 (PLCG1)
09164 Neurodegenerative disease
05012 Parkinson disease
102992700 (PLCG1)
05022 Pathways of neurodegeneration - multiple diseases
102992700 (PLCG1)
09167 Endocrine and metabolic disease
04933 AGE-RAGE signaling pathway in diabetic complications
102992700 (PLCG1)
09171 Infectious disease: bacterial
05135 Yersinia infection
102992700 (PLCG1)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
102992700 (PLCG1)
05171 Coronavirus disease - COVID-19
102992700 (PLCG1)
05167 Kaposi sarcoma-associated herpesvirus infection
102992700 (PLCG1)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
102992700 (PLCG1)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:
pcad04131
]
102992700 (PLCG1)
Enzymes [BR:
pcad01000
]
3. Hydrolases
3.1 Acting on ester bonds
3.1.4 Phosphoric-diester hydrolases
3.1.4.11 phosphoinositide phospholipase C
102992700 (PLCG1)
Membrane trafficking [BR:
pcad04131
]
Exocytosis
Calcium ion-dependent exocytosis
Phospholipases
102992700 (PLCG1)
Endocytosis
Macropinocytosis
Phospholipase C
102992700 (PLCG1)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
PI-PLC-X
SH2
PI-PLC-Y
SH3_1
C2
PH
SH3_9
SH3_2
GDPD
PH_12
PH_9
Motif
Other DBs
NCBI-GeneID:
102992700
NCBI-ProteinID:
XP_028342587
UniProt:
A0A455B1D6
LinkDB
All DBs
Position
Unknown
AA seq
1255 aa
AA seq
DB search
MGPHFSLPVDIREIKEIRPGKTSRDFDRYQEDPAFRPDQSHCFVILYGMEFRLKTLSLQA
TSEDEVNMWIKGLTWLMEDTLQAATPLQIERWLRKQFYSVDRNREDRWVLRCGSSPAGIS
AKDLKNMLSQVNYRVPNMRFLRERLTDLEQRTSDITYGQFAQLYRSLMYSAQKTVHEPPA
PTAPALLSHPSPACLSPAALLGGDWMDLPFLEASSLRAGERPELCRVSLPEFQQFLLEYQ
GELWAVDRLQVQEFMLSFLRDPLREIEEPYFFLDEFVTFLFSKENSIWNSQLDAVCPDTM
NNPLSHYWISSSHNTYLTGDQFSSESSLEAYARCLRMGCRCIELDCWDGPDGMPVIYHGH
TLTTKIKFSDVLHTIKEHAFVASEYPVILSIEDHCSIAQQRNMAQYFKKVLGDTLLTKPV
DIAADGLPSPSQLKRKILIKHKKLAEGSAYEEVPTSVMYSENDISNSIKNGILYLEDPVN
HEWYPHYFVLTSSKIYYSEETSSDQGNEDEEEPKEASGSTELHSNEKWFHGKLGAGRDGR
HIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFWRNGKVQHCRIHSRQDAGTPKFF
LTDNLVFDSLYDLITHYQQVPLRCNEFEMRLSEPVPQTNAHESKEWYHASLTRAQAEHML
MRVPRDGAFLVRKRNEPNSYAISFRAEGKIKHCRVQQEGQTVMLGNSEFDSLVDLVSYYE
KHPLYRKMKLRYPINEEALEKIGTAEPDYGALYEGRNPGFYVEANPMPTFKCAVKALFDY
KAQREDELTFTKSAIIQNVEKQEGGWWRGDYGGKKQLWFPSNYVEEMVSPAALEPEREHL
DENSPLGDLLRGVLDVPACQIAIRPEGKNNRLFVFSISMASVAHWSLDVAADSQEELQDW
VKKIREVAQTADARLTEGKMMERRKKIALELSELVVYCRPVPFDEEKIGTERACYRDMSS
FPETKAEKYVNKAKGKKFLQYNRLQLSRIYPKGQRLDSSNYDPLPMWICGSQLVALNFQT
PDKPMQMNQALFLAGGHCGYVLQPSIMRDEAFDPFDKSSLRGLEPCAICIEVLGARHLPK
NGRGIVCPFVELEVAGAEYDSTKQKTEFVVDNGLNPMWPAKPFHFQISNPEFAFLRFVVY
EEDMFSDQNFLAQATFPVKGLKTGYRAVPLKNNYSEDLELASLLVKVDVYPAKQENGDLS
PFGGASLRERGCDASGQLFHGRAREGSFEARYQQPFEDFRISQEHLADHFDSRER
NT seq
3767 nt
NT seq
+upstream
nt +downstream
nt
atgggtccccatttctctttgccagttgacattcgagaaatcaaggagatccgccccggg
aagacctcacgggacttcgatcgctaccaagaggatcctgcttttcgaccggaccagtca
cactgctttgtcatcctgtatggaatggaattccgcctgaagaccctgagcctgcaagct
acgtctgaggacgaagtgaacatgtggatcaagggcctgacttggctgatggaggatacg
ttgcaggcggccacacccttgcagattgagaggtggctgcggaagcagttttactcagtg
gaccggaatcgtgaggatcggtgggtcctgcgctgtggctctagcccagcaggtatatca
gccaaggacctgaagaacatgctgtcccaggtcaactaccgggtccccaacatgcgcttc
ctccgagagcggctgacggacctggagcagcgcaccagcgatatcacctacgggcagttt
gctcagctgtaccgcagcctcatgtacagcgcccagaagacggtgcatgagccacctgcc
cccaccgcccctgccctgctctcccaccctagccccgcttgcctcagccctgctgccctg
cttgggggcgattggatggacctccccttcctggaagccagttccctgagggcgggggag
cggccggagctctgccgggtgtcccttcctgagttccagcagttcctcctcgagtaccag
ggggagctgtgggctgtcgaccggctccaggtgcaggagttcatgctcagcttcctccga
gaccccttgcgagagattgaggaaccttacttcttcctggacgagttcgtcaccttcctg
ttctccaaggagaacagcatatggaactcgcagctggacgccgtgtgccccgacaccatg
aacaaccccctgtcccactactggatctcctcctcgcacaacacatacctgaccggggac
cagttttccagcgagtcctccctggaagcctacgcccgctgcttgcggatgggctgccgc
tgcattgagttggactgctgggacggtccagacgggatgccagtcatttaccacggacac
accctgaccaccaagatcaagttctcagacgtcctgcacaccatcaaggagcacgccttt
gtggcctcagagtacccggtcatcttgtccatcgaggaccattgcagcatcgcccagcag
aggaacatggcccagtacttcaagaaggtgctcggggacacactcctcaccaagcccgtg
gacatcgctgctgacgggctcccctcacccagccagctcaagaggaagatcctcatcaag
cacaagaagctggctgagggcagtgcctatgaagaggtgcctacatccgtgatgtactct
gagaacgacatcagcaactccatcaagaatggtatcctctacctggaggaccccgtgaat
cacgagtggtatccccactacttcgttctgaccagtagcaagatctactactccgaggag
accagcagtgaccagggcaacgaggatgaggaggagcccaaggaggccagtggcagcaca
gagctgcactccaacgagaagtggtttcacgggaagctcggggcgggacgggacgggcgg
cacatcgccgagcgcctgctcacggagtactgcatcgagaccggggcccccgacggctcc
ttcctcgtgcgcgagagcgagaccttcgtgggcgactacaccctctccttctggcggaac
ggcaaagtccagcactgccggatccactcccggcaggacgcagggacccccaagttcttc
ctgacagacaacctcgtcttcgactcactctatgacctcatcacacactaccagcaggtg
cccctgcgctgcaacgaatttgagatgcgcctctcagagcccgtcccgcagaccaacgcc
catgagagcaaagagtggtaccacgcgagcctgaccagagcgcaggccgagcacatgctg
atgcgcgtcccccgggacggggccttcctggtgcggaaacggaatgagcccaactcctac
gccatctccttccgggctgagggcaagatcaagcactgccgcgtccagcaggagggccag
accgtgatgctgggcaactcagagtttgacagcctcgtggacctcgtcagctactacgag
aagcaccccctgtaccgcaagatgaagctacgctatcccatcaacgaggaggcgctggag
aagatcggcacagcggagcccgactacggggccctgtatgagggccgcaaccccggcttc
tacgtggaggcgaaccccatgccgactttcaagtgcgccgtcaaagctctcttcgactac
aaggcccagagagaggacgagctgactttcaccaagagcgccatcatccagaacgtggag
aagcaggaaggaggctggtggcgtggtgactatggtgggaagaagcagctgtggttcccg
tcgaactacgtggaagagatggtcagccctgcggccctggagcctgagagggagcacttg
gacgagaacagccccctgggggacttgctgcggggggtcttggatgtgccggcttgtcag
atagccatccgtcctgagggcaagaacaaccggctcttcgtcttctccatcagcatggcg
tcggtggcacactggtccctagatgtggctgccgactcacaggaggagctgcaggactgg
gtgaaaaagatccgggaagtggcccagaccgcggatgccaggctcactgaggggaagatg
atggagcggaggaagaagatcgccctggagctctccgagcttgtcgtctactgccggcct
gttcccttcgacgaagagaagatcggcacagaacgcgcctgctaccgggacatgtcatcc
ttcccggaaaccaaggctgagaagtacgtgaacaaggccaaaggcaaaaagttcctccag
tacaaccggctgcagctctcccgcatctaccccaagggccagcggctggactcctccaat
tacgaccccttgcccatgtggatctgtggcagtcagctggtggccctcaacttccagacc
ccagacaagcctatgcagatgaaccaggccctcttcctggccggcgggcactgtggctac
gtgctgcagccgagcatcatgcgcgatgaggccttcgacccctttgacaagagcagcctc
cgcgggctggagccgtgtgccatctgcatcgaggtgctgggggcccggcatctgccgaag
aatggccgaggtatcgtgtgtcctttcgtggagcttgaggtggccggtgctgagtatgac
agcaccaagcagaagacggagtttgtggtggacaatggactgaaccccatgtggccagcc
aagcccttccacttccagatcagtaaccccgaattcgccttcctgcgctttgtggtgtat
gaggaagacatgtttagtgaccagaacttcctggctcaggctaccttccctgtgaagggc
ctgaagacaggatacagagcagtgcctttgaagaacaactatagcgaggacctggagttg
gcctccctgctcgtcaaggtcgacgtttaccctgccaagcaggagaacggtgacctcagt
ccctttgggggtgcgtccctgcgggagcggggctgcgacgcctcgggccagctgtttcat
ggccgggcccgggaaggctccttcgaagctcgctaccagcagccgtttgaggacttccgc
atttcccaggagcatctcgccgaccattttgacagtcgggaacgaag
DBGET
integrated database retrieval system